Sylvatica Biotech Inc. has been awarded a $549,604 firm fixed price contract by the Department of the Army Medical Command to further develop a novel cryostasis cocktail and protocol for high subzero banking of human organs under the Small Business Innovation Research Program Phase II Enhancement. The research will build upon Sylvatica's prior Phase I SBIR work to advance organ cryopreservation technology. The total small business set aside contract will be performed in Charleston, South Carolina through June 2023. The award provides continued support for Sylvatica's efforts to establish protocols and solutions aimed at extending organ viability for transplantation through ultra-low temperature storage.
Generated 12/25/23, 1:44 AM